Our story
- About us
- Latest
- Centres
Our science
- Mission
  - Discover
  - Develop
  - Deliver
- Approaches
- Explore by
Our people
- Researchers
- Governance
- Latest
  
  Sep 10, 2024 - Update
  
  Shaping the future of dementia research: Meet the UK DRI’s newest Emerging Leaders
  
  We are pleased to announce three new UK DRI Emerging Leaders: Dr Maura Malpetti, Dr...
  Learn more Shaping the future of dementia research: Meet the UK DRI’s newest Emerging Leaders
Our partners
- Partnerships
- Initiatives
  - Dementia Trials Accelerator (DTA)
  - CURE-ND
- Latest
  
  Jan 01, 2024 - Feature
  
  Why partner with the UK DRI?
  
  The UK DRI is central to a rich and connected dementia research ecosystem, and we...
  Learn more Why partner with the UK DRI?
Careers
- Join us
  - Vacancies
  - Centres
- Latest
  
  Jan 01, 2024 - Feature
  
  Why join the UK DRI?
  
  By joining the UK DRI you’ll belong to a team of world-class researchers, technical specialists...
  Learn more Why join the UK DRI?
Public Information
- Information
- Dementias
- Movement conditions

J Neurol Neurosurg Psychiatry

Published Jan 01, 1970

Plasma GFAP in presymptomatic and symptomatic familial Alzheimer's disease: a longitudinal cohort study.

Authors

Antoinette O'Connor, Emily Abel, Andrea Lessa Benedet, Teresa Poole, Nicholas Ashton, Philip Simon John Weston, Amanda J Heslegrave, Natalie Ryan, Suzie Barker, James M Polke, Kaj Blennow, Henrik Zetterberg, Nick C Fox

Read More

Abstract

PMID:35948396 | DOI:

UK DRI Authors

Prof Henrik Zetterberg

Group Leader

Pioneering the development of fluid biomarkers for dementia

Prof Henrik Zetterberg